Cargando…
SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer
BACKGROUND: SMARCA4/BRG1 protein–deficient lung adenocarcinomas and thoracic sarcoma are recently described entities that lack distinctive histological features, transcription termination factor 1 (TTF1) reactivity, and actionable driver mutations. The current diagnostic path for small lung biopsies...
Autores principales: | Mehta, Anurag, Bansal, Divya, Tripathi, Rupal, Jajodia, Ankush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists/The Korean Society for Cytopathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476316/ https://www.ncbi.nlm.nih.gov/pubmed/34147056 http://dx.doi.org/10.4132/jptm.2021.05.11 |
Ejemplares similares
-
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
por: Mehta, Anurag, et al.
Publicado: (2022) -
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
por: Karnezis, Anthony N, et al.
Publicado: (2015) -
Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
por: Meng, Xiangpeng, et al.
Publicado: (2023) -
Cellular Expression of Smarca4 (Brg1)-regulated Genes in Zebrafish Retinas
por: Hensley, Monica R, et al.
Publicado: (2011) -
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism
por: Orlando, Krystal Ann, et al.
Publicado: (2020)